No Differences in Kidney Function Decline Between People with Type 2 Diabetes Starting a Sodium-Glucose Cotransporter 2 Inhibitor or a Glucagon-like Peptide-1 Receptor Agonist: A Real-world Retrospective Comparative Observational Study

Sara Bodini,Silvia Pieralice,Luca D'Onofrio,Carmen Mignogna,Lucia Coraggio,Rocco Amendolara,Renata Risi,Mauro Salducci,Raffaella Buzzetti,Ernesto Maddaloni

Clinical Therapeutics（2024）

引用 0|浏览4

关键词

Chronic kidney disease,Diabetes mellitus,Diabetic nephropathy,GLP1RA,Glucagon-like peptide-1 receptor agonist,Nephroprotective action,SGLT2i,Sodium-glucose cotransporter 2 inhibitor

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要